Press Releases

Microbiosci Develops Microbial Cell Line Generation for Therapeutics and Diagnostic Applications

Dec 28, 2022
Creative Biogene Has Developed GMP Lentivirus Production Service to Accelerate Cell Therapy and Gene Therapy

Dec 28, 2022
Histobiolab Releases Over 150 FISH Probes for Hematology, Pathology and Constitutional Cytogenetics

Dec 28, 2022
CD ComputaBio Releases AutoDock Vina Software to Accelerate Molecular Docking Projects

Dec 26, 2022
Analyzing Protein Structures with Pronalyse’s Hydrogen Deuterium Exchange Mass Spectrometry

Dec 25, 2022
Creative Proteomics Cytokine Launches Growth Factors (GF) Detection Service for Your Research

Dec 17, 2022
Creative Proteomics Launches SPR-based Biacore Service to Help Study Biomolecular Interactions

Dec 12, 2022
CRISPR Off-Target Analysis Now Available with CD Genomics’ Bioinformatics-Analysis Platform

Dec 25, 2022
CD Genomics RNA-Solutions Platform Unveils m7G MeRIP Sequencing for Scientific Research

Dec 25, 2022
Creative Enzymes Offers Personalized and Customized Probiotic Blends

Dec 22, 2022
Novel Melanoma Diagnostic Tool: MicroRNAs-Associated Extracellular Vesicles Endorsed by Creative Biolabs

Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma.
Dec 19, 2022
Profacgen Enhanced Its CLIP-Seq Service for RNA-Protein Interaction Research

Dec 13, 2022
ScyTek announces a new special stain kit, The Martius Scarlet Blue (MSB) Stain Kit.

ScyTek Biotech Life Sciences manufactures diagnostic reagents, Special Stains, Antibodies, Hematology, Immunohistochemistry, buffers, Microbiology, Hematoxlyn etc https://www.scytek.com
Dec 13, 2022
OVER £175 MILLION FOR CUTTING-EDGE GENOMICS RESEARCH TO HELP BOOST DIAGNOSIS AND TREATMENT FOR PATIENTS

Genomics England has announced funding of £105 million to kickstart a world-leading research study, in partnership with the NHS, to explore the effectiveness of using whole genome sequencing to find and treat rare genetic diseases in newborn babies.
Dec 13, 2022
New startup Graegis Pharmaceuticals to prevent skin and mucosa side effects of radiotherapy

Graegis Pharmaceuticals has announced its plan to start proof-of-concept clinical trials in 2023 in the prevention of radiation-induced dermatitis and mucositis.
Dec 5, 2022
CLINICAL REFERENCE MATERIALS TO SUPPORT TOTAL CHOLESTEROL, HDL, AND LDL ASSAYS

Nov 30, 2022
CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis

Nov 30, 2022
Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process

Nov 21, 2022
Creative Proteomics Lipidomics Launches Ceramides Analysis Service

Nov 12, 2022
Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

Nov 14, 2022